Review Test Submission:
Week 6 Midterm Exam
Course NURS-6630N-7,Approaches to Treatment.2018 Winter Qtr
11/26-02/17-PT27
Test Week 6 Midterm
... [Show More] Exam
Started 1/4/19 9:14 PM
Submitted 1/4/19 9:59 PM
Due Date 1/7/19 1:59 AM
Status Completed
Attempt Score 64 out of 75 points
Time Elapsed 44 minutes out of 2 hours
Results
Displayed
Submitted Answers
Question 1
0 out of 1 points
A noncompliant patient states, “Why do you want me to put this poison in my body?”
Identify the best response made by the psychiatric-mental health nurse practitioner
(PMHNP).
Selected
Answer:
D.
“Why do you believe that your medication is
poison?”
Question 2
0 out of 1 points
Ms. Hill is currently being treated for schizophrenia but has stopped taking
her medications due to some side effects she claims she was experiencing.
She presents to the clinic today with worsening symptoms. She is
experiencing anhedonia, agitation, attentional impairment, and affective
blunting. Which one of the symptoms mentioned is considered a positive
symptom of schizophrenia?
Selected
Answer:
C.
Attentional Impairment
Question 3
1 out of 1 points
Which statement about neurotransmitters and medications is true?
NURS 6630-7 WEEK 6 MIDTERM EXAM WALDEN
Selected
Answer:
B.
Several psychiatric medications have been developed after discoveries of endogenous
neurotransmitters and defining their function in the brain.
Question 4
1 out of 1 points
When an unstable patient asks why it is necessary to add medications to his current
regimen, the PMHNP’s best response would be:
Selected
Answer:
C.
“Many psychiatric illnesses involve several dys-functioning neurotransmitter systems in
the brain. Often, a single medication may only effect one or two of the dys-functioning
systems. The addition of another medication can work with the current medication in
stabilizing multiple neurotransmitter systems and help to alleviate your symptoms.”
Question 5
1 out of 1 points
During gene expression, what must occur prior to a gene being expressed?
Selected
Answers:
A.
Transcription factor must bind to the regulatory region within the
cell’s nucleus.
Question 6
1 out of 1 points
While genes have potential to modify behavior, behavior can also modify genes. How do
genes impact this process?
Selected
Answer:
B.
Changes made to proteins lead to changes in
behavior.
Question 7
1 out of 1 points
Though medications have the ability to target neurotransmitter release into the synapse by the
presynaptic neuron it is not always necessary. The PMHNP understands that this is because:
Selected
Answer:
C.
Neurotransmitters can spread by
diffusion.
Question 8
1 out of 1 points
Why is the cytochrome P450 enzyme system of significance to the PMHNP?
Selected
Answer:
B.
The bioavailability of the medication after it passes through the stomach
and liver can be altered.
Question 9
1 out of 1 points
It is important for the PMHNP to recognize differences in pharmacokinetics to safely
prescribe and monitor medications. Which of the following statements does the competent
PMHNP identify as true?
Selected
Answer:
A.
About 1 out of 5 Asians requires lower-than-normal doses of some
antidepressants and antipsychotics.
Question 10
1 out of 1 points
As it relates to G-protein linked receptors, what does the PMHNP understand about
medications that are used in practice?
Selected
Answer:
A.
Most medications that act on G-protein linked receptors have
antagonistic traits.
Question 11
1 out of 1 points
The PMHNP is considering prescribing a 49-year-old male clozapine (Clozaril) to treat his
schizophrenia and suicidal ideations. The PMHNP is aware that which factor may impact
the dose needed to effectively treat his condition:
Selected
Answer:
A.
The patient smokes
cigarettes.
Question 12
0 out of 1 points
A patient is diagnosed with bipolar disorder and is currently taking carbamazepine
(Tegretol), aripiprazole (Abilify), and melatonin. The PMHNP has just written an order to
discontinue the carbamazepine (Tegretol) for drug-induced thrombocytopenia. The PMHNP
is aware that his next best action is to:
Selected
Answer:
B.
Write an order for a different mood
stabilizer
Question 13
1 out of 1 points
A patient recently transferred following a suicide attempt has a history of schizophrenia,
depression, and fibromyalgia. He is currently taking Amitriptyline (Elavil), Lisinopril, aspirin,
and fluoxetine (Prozac). When assessing the psychiatric medications and the reason for admission,
what would be the best course of action for the PMHNP with this client?
Selected
Answer:
A.
Review Amitriptyline (Elavil)
level
Question 14
0 out of 1 points
A patient with schizophrenia is given an inverse agonist that acts on the receptor 5HT and
neurotransmitter serotonin. What is the rationale for prescribing a medication such as this?
Selected
Answer:
D.
To help decrease the amount of serotonin and
dopamine
Question 15
1 out of 1 points
The PMHNP is caring for four patients. Which patient statement indicates that
benzodiazepines would be beneficial?
Selected
Answer:
D.
“I feel nervous to go outside and be in large
crowds.”
Question 16
1 out of 1 points
Ms. Harlow is a 42-year-old patient who is prescribed a drug that acts on ionotropic
receptors. She is curious about the effects of the drug and how it will act on her symptoms.
Which statement made by the PMHNP demonstrates proper understanding of Ms. Harlow’s
prescription?
Selected
Answer:
A.
“The drug will have an almost
immediate effect.”
Question 17
1 out of 1 points
A patient is seeking pharmacological treatment for smoking cessation. Which drug class
does the PMHNP prescribe to the patient?
Selected
Answer:
D.
Varenicline
(Chantix)
Question 18
1 out of 1 points
The PMHNP is caring for a new patient who has been transferred from another office. When
meeting with the new patient, the patient reports, “I feel like I am improving with the
stabilizers.” The PMHNP immediately recognizes that the patient is describing which kind
of drug?
Selected
Answer:
C.
Partial
agonists
Question 19
1 out of 1 points
A patient presents with frequent episodes of mania. Which statement describes an
appropriate treatment approach for this patient?
Selected
Answer:
B.
“The patient could benefit from an
anticonvulsant.”
Question 20
1 out of 1 points
What characteristics do the nicotinic, cholinergic, serotonin 3, and glycine receptors all have in
common?
Selected
Answer:
A.
Ligand-gated ion channels with a pentameric
structure
Question 21
1 out of 1 points
Which statement made by the patient suggests the patient will need to be treated with
antipsychotics that target paranoid psychosis?
Selected
Answer:
B.
“I have to talk to the President because I’m the only one who
can help him.”
Question 22
1 out of 1 points
Mr. McCullin is 64 years old with Parkinson’s disease. The PMHNP caring for Mr. McCullin
wants to start him on a dopamine agonist to help manage and treat his condition. The
PHMNP selects this agent because of which action it has on patients like Mr. McCullin?
Selected
Answer:
D.
D2 receptors are the primary binding site for
dopamine agonists.
Question 23
1 out of 1 points
Mrs. Trevor is a 44-year-old patient who does not have a diagnosis of schizophrenia but
occasionally reports symptoms of psychosis, followed by severe fatigue. Mrs. Trevor
inquires about the use of amphetamines to help with her energy levels. Which response
made by the PMHNP is most appropriate?
Selected
Answer:
C.
“Amphetamines can cause hallucinations, so I would advise against this
type of prescription.”
Question 24
1 out of 1 points
The PMHNP is caring for a patient with schizophrenia and is considering a variety of
treatment approaches. The PHMNP selects a viable treatment that is consistent with the
“dopamine hypothesis of schizophrenia.” What action does the PMHNP anticipate this
treatment having on the patient?
Selected
Answer:
B.
Hyperactivity in the mesolimbic dopamine pathway mediates the positive
symptoms of schizophrenia.
Question 25
0 out of 1 points
A patient is diagnosed with schizophrenia. What increases the patient’s potential to
mediate the cognitive symptoms of the disease?
Selected
Answer:
B.
Achieving overactivity of the mesocorticol proj [Show Less]